Why is a vegan-food startup avoiding the term “vegan”?
The Atlantic
Posted inEditor's Pick
Mayonnaise, Disrupted
Is Josh Tetrick’s vegan-mayo company just another over-promising, under-delivering startup?
Posted inArts & Culture, Nonfiction, Quotes, Science & Nature
Mothering Is Not the Enemy of Creative Work
Journalist Erika Hayasaki uses science to show how motherhood can improve creativity.
Posted inArts & Culture, Current Events, History, Uncategorized
Ta-Nehisi Coates Takes on the Trump Presidency
In an excerpt from his upcoming book on the Obama administration, Coates constructs an incisive look at Donald Trump’s political ascent.
Posted inTop 5
The Top 5 Longreads of the Week
This week, we’re sharing stories from Ta-Nehisi Coates; Nikole Hannah-Jones; Mark Collette, David Hunn, and Mike Hixenbaugh; Natalie Kitroeff and Victoria Kim; and Robert Minto.
Posted inNonfiction, Quotes
Working Class Jilts America’s Sweetheart Deal
The working class is walking away from America’s favorite business transaction — traditional marriage — as good jobs disappear.
Posted inTop 5
The Top 5 Longreads of the Week
This week, we’re sharing stories from Bee Wilson, Seyward Darby, Wil S. Hylton, Greg Milner, and Annie Dillard.
Posted inNonfiction, Quotes
The Sun Was Going and the World Was Wrong
Annie Dillard describes her experience of the 1979 solar eclipse, the last one visible in the United States until this year.
Posted inEditor's Pick
Annie Dillard’s Classic Essay: ‘Total Eclipse’
Dillard’s 1982 personal essay — excerpted by The Atlantic from her new collection, The Abundance: Narrative Essays Old and New. She writes in exquisite detail about the haunting, surreal experience of witnessing the last solar eclipse, on February 26th, 1979, after driving five hours inland in Washington State to catch it from a hill top.
Posted inCurrent Events, Science & Nature
Swabbing Filthy Surfaces for Tomorrow’s Cures
As the world faces a global health catastrophe from drug-resistant microbes, one scientists is searching the natural world for the antibiotics of the future.